Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis (HIT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Institut Curie
Sponsor:
Collaborators:
Hoffmann-La Roche
Centre Leon Berard
Groupe Hospitalier Pitie-Salpetriere
Centre Oscar Lambret
Centre Francois Baclesse
Institut Bergonié
University Hospital, Toulouse
Institut du Cancer de Montpellier - Val d'Aurelle
University Hospital, Grenoble
Information provided by (Responsible Party):
Institut Curie
ClinicalTrials.gov Identifier:
NCT01373710
First received: May 24, 2011
Last updated: July 8, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2019
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)